Computed tomographically‐controlled injection of botulinum toxin into the longus colli muscle in severe anterocollis

Herting, Birgit; Wunderlich, Silke; Glöckler, T; Bendszus, Martin; Mucha, Dirk; Reichmann, Heinz; Naumann, Markus

doi:10.1002/mds.10704

Cited by 32 publications

(21 citation statements)

References 14 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because of the weak effect he did not return to treatment earlier than after 2 years when he received 35 MU of onaBTXA into each sternocleidomastoid muscle and 30 MU onaBTXA into the right longus colli muscle under CT-guidance [39]. Injections were repeated several times and the patient reported subjective improvement of 40% on a visual analogue scale from 0 to 100 [39]. Only the second injection led to mild dysphagia.…”

Section: Dosingmentioning

confidence: 97%

“…Three patients reported weakness of the extensor muscles as a side effect [38]. In a 44-yearold male with severe CACOL, treatment started with 300 MU of aboBTXA in each sternocleidomastoid muscle with little benefit [39]. Because of the weak effect he did not return to treatment earlier than after 2 years when he received 35 MU of onaBTXA into each sternocleidomastoid muscle and 30 MU onaBTXA into the right longus colli muscle under CT-guidance [39].…”

Section: Dosingmentioning

confidence: 98%

“…In a 44-yearold male with severe CACOL, treatment started with 300 MU of aboBTXA in each sternocleidomastoid muscle with little benefit [39]. Because of the weak effect he did not return to treatment earlier than after 2 years when he received 35 MU of onaBTXA into each sternocleidomastoid muscle and 30 MU onaBTXA into the right longus colli muscle under CT-guidance [39]. Injections were repeated several times and the patient reported subjective improvement of 40% on a visual analogue scale from 0 to 100 [39].…”

Section: Dosingmentioning

confidence: 99%

See 2 more Smart Citations

Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift

Finsterer

Maeztu²,

Revuelta

et al. 2015

Journal of the Neurological Sciences

View full text Add to dashboard Cite

Section: Dosingmentioning

confidence: 97%

Section: Dosingmentioning

confidence: 98%

Section: Dosingmentioning

confidence: 99%

See 1 more Smart Citation

Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift

Finsterer

Maeztu²,

Revuelta

et al. 2015

Journal of the Neurological Sciences

View full text Add to dashboard Cite

“…However, the procedure needs a fluoroscopic EMG-guided approach in an operation room and requires patient sedation. 6,7 The motor improvement achieved by injecting the lower SCM versus the upper SCM could be related to the dynamic progression of anterocollis associated with a chronic increase of intramuscular nerve endings in the distal SCM compared with controls. A recent pathologic study in nondystonic patients reported the presence of 85% of intramuscular nerve ending points located at 20% to 70% of the line from mastoid process to clavicle, and suggested the injection of BoNT in upper SCM at 20% to 40% and lower SCM at 50% to 70% as probable effective points.…”

mentioning

confidence: 97%

Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis

2016

View full text Add to dashboard Cite

Anterocollis is a type of cervical dystonia characterized by simultaneous and repetitive antagonist muscles contractions, resulting in abnormal neck flexion. It was described with a frequency of 6.8% from 399 patients with diagnosis of cervical dystonia and usually coexists with torticollis and/or laterocollis, as mixed cervical dystonia patterns. Botulinum toxin is usually a practical and effective treatment for cervical dystonia. The target muscles to inject in anterocollis are usually sternocleidomastoid and scalene muscles. There is also a case report suggesting longus collis involvement. Nevertheless, the dosage of the medication in anterocollis is limited by frequent side effects of dysphagia. We described 2 cases of refractory anterocollis. They did not benefit from conventional bilateral upper portion of sternocleidomastoid muscle injections with OnabotulinumtoxinA, but notably improved their symptoms and clinical global impression after switching to injections into bilateral lower portion of sternocleidomastoid muscles, without significant side effects.

show abstract

“…Herting et al (2004) reported a case of a patient, suffering from severe anterocollis, where repeated computer tomography (CT)-controlled injections of BoNT into the right longus colli muscle allowed a precise location of the needle and injection of the toxin, leading to an obvious improvement of symptoms[85].…”

mentioning

confidence: 99%

How Useful are Localization Techniques in Botulinum Toxin Injections for Dystonia and Spasticity Indications?

Semerdjieva¹

2016

Botulinum Toxin Therapy Manual for Dystonia and Spasticity

View full text Add to dashboard Cite

There is irrefutable evidence for the effectiveness of botulinum toxin (BoNT) in the treatment of various disorders associated with excessive muscle contraction or autonomic dysfunction. One of the earliest indications as well as the most common BoNT treated movement disorder is dystonia, predominantly its focal forms, including blepharospasm, oromandibular, spasmodic, cervical and limb dystonia. Spastic disorders comprise another area where BoNT treatment has proved beneficial. Optimal therapeutic results, however, depend on several factors, including the BoNT serotype, dose, concentration, injected volume, frequency of application, as well as precise localization of the muscles producing the abnormal movement. The accuracy in targeting muscle localization is considered to be a key factor for determining the outcome of BoNT injections, even more important than dilution volume and dose. Various techniques to find the best injection site for the delivery of BoNT have been described in the literature. An attempt was made to summarize in one place the available evidence, and when possible to compare and point out the advantages and disadvantages of different techniques for localization of BoNT injections. The widely applied clinical indications for dystonia and spasticity have been specifically chosen as our focus in this present work.

show abstract

Computed tomographically‐controlled injection of botulinum toxin into the longus colli muscle in severe anterocollis

Abstract: We report on a 44-year-old man who suffered from severe anterocollis. Repeated computed tomographically controlled injections of botulinum toxin into the right longus colli muscle allowed a precise location of the needle and injection of the toxin, leading to clear improvement of symptoms.

Cited by 32 publications

References 14 publications

Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift

Collum-caput (COL-CAP) concept for conceptual anterocollis, anterocaput, and forward sagittal shift

Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis

How Useful are Localization Techniques in Botulinum Toxin Injections for Dystonia and Spasticity Indications?

Contact Info

Product

Resources

About